Doctors are using low-intensity electromagnetic fields to treat cancer patients, with the ability to specifically target cancer cells without damaging healthy tissue.
Professor Boris Pasche and colleagues have developed a novel treatment that uses very low intensity radiofrequency waves, modulated to target specific types of cancer.
The treatment is administered via a TheraBionic device.
It is based on the incredible finding that different types of cancer correspond to different frequencies. In this way, patients receive a prescription frequency corresponding to the type of cancer.
Currently, most of the research has been done with liver cancer patients (hepatocellular carcinoma). Liver cancer is a particularly difficult condition to treat - the very nature of the condition means that patients cannot tolerate the medications that might normally be used.
With current available treatments, patients with hepatocellular carcinoma have a very limited life expectancy, ranging from 6-12 months. In the video clip below Professor Pasche explains how some patients have continued to survive for several years with the use of the TheraBionic device.
Professor Pasche has impeccable credentials, including: Charles L. Spurr Professor of Medicine, Chairman of the Department of Cancer Biology and Director of the Comprehensive Cancer Center at Wake Forest University Medical Center. He is also Associate Editor, Hematology/Oncology and Cancer Genetics for The Journal of the American Medical Association.
Potential for Treating Other Types of Cancer
Professor Pasche and colleagues are focussed on the treatment of liver cancer for the purpose of current clinical trials, and to provide even more data on efficacy. However, during the development of the treatment, significant benefits have been seen in other types of cancer.
For example, Professor Paul Rosch has previously written:
"Treatment is completely safe, has no side effects, and can be administered by patients at home for 1 h, three times a day, during which they can watch TV or read. It consists of administering radiofrequency waves that are specific for this tumor by means of a spatula like device that is held in the mouth like a lollipop. It can also be programmed for other malignancies, and one patient with breast cancer that had metastasized to the adrenal gland and bone, had a “complete response” after an 11-month treatment. A patient with stage IV thyroid cancer metastatic to the lungs has received continuous treatment for more than 7 years. Because of this and subsequent developments, It seems likely that in the future, doctors will be prescribing frequencies, rather than pushing pills."
Targeting Cancer Cells, Leaving Healthy Tissue in Tact.
This type of specific radiofrequency treatment is particularly beneficial because it targets the cancer cells and not the healthy tissue. This specificity of the treatment has been confirmed using various experiments and by monitoring the patients blood tests.
In the second video (below) Hugo Jimenez, a researcher at Wake Forest University Medical Center, describes some of the ways that the team are investigating the mechanism of action.